Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Antimicrob Agents Chemother ; 51(11): 4160-2, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17709468

ABSTRACT

Recombinant phenotyping of cytomegalovirus (CMV) pol region III mutations from clinical specimens showed that T813S and G841A each conferred foscarnet resistance and approximately threefold increased ganciclovir resistance; adding the UL97 mutation C592G increased ganciclovir resistance to approximately sixfold. Bacterial artificial chromosome CMV clones containing pol mutation L845P were nonviable unless repaired with the wild-type sequence.


Subject(s)
Antiviral Agents/pharmacology , Cytomegalovirus/drug effects , DNA-Directed DNA Polymerase/genetics , Drug Resistance, Viral/genetics , Mutation , Cytomegalovirus/genetics , Cytomegalovirus/growth & development , Cytomegalovirus Infections/virology , Foscarnet/pharmacology , Ganciclovir/pharmacology , Genotype , Humans , Phenotype
2.
Antimicrob Agents Chemother ; 50(7): 2557-9, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16801445

ABSTRACT

The cytomegalovirus UL97 kinase inhibitor maribavir suppressed viral growth more effectively in lung fibroblasts than in skin fibroblasts, and some cellular kinase inhibitors enhanced its antiviral activity. These effects influence the phenotypic assay of drug susceptibility and suggest the possibility of therapeutically useful combinations of maribavir and cellular kinase inhibitors.


Subject(s)
Antiviral Agents/pharmacology , Benzimidazoles/pharmacology , Cytomegalovirus/drug effects , Cytomegalovirus/growth & development , Ribonucleosides/pharmacology , Alkaline Phosphatase/genetics , Alkaline Phosphatase/metabolism , Cells, Cultured , Cytomegalovirus/enzymology , Fibroblasts/virology , Genes, Reporter , Humans , Lung/cytology , Lung/virology , Skin/cytology , Skin/virology , Virus Cultivation/methods
3.
Genetics ; 172(1): 343-53, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16219785

ABSTRACT

The family of mammalian O-mannosyltransferases includes two enzymes, POMT1 and POMT2, which are thought to be essential for muscle and neural development. Similar to mammalian organisms, Drosophila has two O-mannosyltransferase genes, rotated abdomen (rt) and DmPOMT2, encoding proteins with high homology to their mammalian counterparts. The previously reported mutant phenotype of the rt gene includes a clockwise rotation of the abdomen and defects in embryonic muscle development. No mutants have been described so far for the DmPOMT2 locus. In this study, we determined that the mutation in the twisted (tw) locus, tw(1), corresponds to a DmPOMT2 mutant. The twisted alleles represent a complementation group of recessive mutations that, similar to the rt mutants, exhibit a clockwise abdomen rotation phenotype. Several tw alleles were isolated in the past; however, none of them was molecularly characterized. We used an expression rescue approach to confirm that tw locus represents DmPOMT2 gene. We found that the tw1 allele represents an amino acid substitution within the conserved PMT domain of DmPOMT2 (TW) protein. Immunostaining experiments revealed that the protein products of both rt and tw genes colocalize within Drosophila cells where they reside in the ER subcellular compartment. In situ hybridization analysis showed that both genes have essentially overlapping patterns of expression throughout most of embryogenesis (stages 8-17), while only the rt transcript is present at early embryonic stages (5 and 6), suggesting its maternal origin. Finally, we analyzed the genetic interactions between rt and tw using several mutant alleles, RNAi, and ectopic expression approaches. Our data suggest that the two Drosophila O-mannosyltransferase genes, rt and tw, have nonredundant functions within the same developmental cascade and that their activities are required simultaneously for possibly the same biochemical process. Our results establish the possibility of using Drosophila as a model system for studying molecular and genetic mechanisms of protein O-mannosylation during development.


Subject(s)
Drosophila Proteins , Drosophila melanogaster , Mannosyltransferases/genetics , Mannosyltransferases/metabolism , Amino Acid Sequence , Amino Acid Substitution , Animals , Animals, Genetically Modified , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Drosophila melanogaster/embryology , Drosophila melanogaster/enzymology , Drosophila melanogaster/genetics , Embryonic Development/physiology , Female , Gene Expression Regulation, Developmental , Genetic Complementation Test , In Situ Hybridization , Male , Molecular Sequence Data , Mutation , Phenotype , RNA, Small Interfering/pharmacology , Sequence Homology, Amino Acid
4.
Antimicrob Agents Chemother ; 49(7): 2710-5, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15980340

ABSTRACT

A new recombinant phenotyping method was developed for the analysis of drug resistance mutations in human cytomegalovirus (CMV). CMV strain T2211 was derived from strain AD169 by inserting unique restriction sites and a secreted alkaline phosphatase (SEAP) reporter gene for rapid viral quantitation. Specific viral UL97 and pol gene mutations were transferred by recombination into T2211, and their drug resistance phenotypes (for ganciclovir, foscarnet, or cidofovir) were determined by the drug concentrations required to reduce supernatant SEAP activity by 50% (IC50). Changes in the IC50 conferred by the mutations tested (UL97 M460V, C592G, A594V, and L595S and pol del981-2) were similar to those previously reported in marker transfer and conventional plaque reduction assays. The combination of UL97 C592G and pol del981-2 conferred much higher ganciclovir resistance than either mutation alone. The UL97 polymorphism D605E had no measurable effect on ganciclovir susceptibility, alone or in combination with common UL97 resistance mutations. Transfer into strain T2211 facilitates the phenotyping of newly observed mutations, combinations of mutations, and clinical CMV sequences without an accompanying viral isolate.


Subject(s)
Antiviral Agents/pharmacology , Cytomegalovirus/drug effects , Drug Resistance, Viral/genetics , Genes, Reporter , Mutation , Recombination, Genetic , Alkaline Phosphatase/genetics , Alkaline Phosphatase/metabolism , Cells, Cultured , Cytomegalovirus/genetics , Cytomegalovirus/growth & development , Gene Products, pol/genetics , Humans , Microbial Sensitivity Tests , Phenotype , Phosphotransferases (Alcohol Group Acceptor)/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...